Compare Medtronic PLC (MDT) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

MSTU, a 2x leveraged ETF tracking MicroStrategy, trades at $1.98 with a 6.45% daily gain but remains in a severe long-term downtrend, having lost over 95% in the past year. Technical indicators are bearish, with moving averages signaling strong selling pressure. The fund's performance is directly tied to MicroStrategy's stock, which is heavily influenced by Bitcoin price volatility, and recent news highlights extreme investor losses and high-risk nature of leveraged products.

The outlook for MSTU is highly speculative and risky, with potential for parabolic gains if Bitcoin surges but extreme downside risk during volatility. Investment suitability is limited to aggressive traders comfortable with total loss potential, given the fund's decay mechanisms and dependency on crypto market sentiment rather than traditional fundamentals.